HomeSGX-LISTED COMPANIESCapAllianz Holdings FY2025 Financial Performance

CapAllianz Holdings FY2025 Financial Performance

Published on

spot_img

CapAllianz Holdings Limited navigated a complex financial year, reporting a comprehensive loss amidst declining overall revenue. However, the Group saw positive developments in its technical services income and generated cash from operating activities, with strategic new business ventures also on the horizon.

• Discover how shifts in core oil and gas operations influenced the Group’s performance

• Explore the positive momentum from the technical services segment, providing a brighter spot

• Uncover a strategic expansion into a new wholesale trading venture post-year-end

LISTEN TO THE PODCAST BELOW:

Latest articles

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...

More like this

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...